University Institute on Addictions, 49987CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montréal, Québec, Québec.
Department of Psychiatry and Addiction, University of Montréal, Montréal, Québec, Canada.
Can J Psychiatry. 2022 Feb;67(2):117-129. doi: 10.1177/07067437211043446. Epub 2021 Sep 27.
Assessing temporal changes in the recorded diagnostic rates, incidence proportions, and health outcomes of substance-related disorders (SRD) can inform public health policymakers in reducing harms associated with alcohol and other drugs.
To report the annual and cumulative recorded diagnostic rates and incidence proportions of SRD, as well as mortality rate ratios (MRRs) by cause of death among this group in Canada, according to their province of residence.
Analyses were performed on linked administrative health databases (AHD; physician claims, hospitalizations, and vital statistics) in five Canadian provinces (Alberta, Manitoba, Ontario, Québec, and Nova Scotia). Canadians 12 years and older and registered for their provincial healthcare coverage were included. The International Classification of Diseases (ICD-9 or ICD-10 codes) was used for case identification of SRD from April 2001 to March 2018.
During the study period, the annual recorded SRD diagnostic rates increased in Alberta (2001-2002: 8.0‰; 2017-2018: 12.8‰), Ontario (2001-2002: 11.5‰; 2017-2018: 14.4‰), and Nova Scotia (2001-2002: 6.4‰; 2017-2018: 12.7‰), but remained stable in Manitoba (2001-2002: 5.5‰; 2017-2018: 5.4‰) and Québec (2001-2002 and 2017-2018: 7.5‰). Cumulative recorded SRD diagnostic rates increased steadily for all provinces. Recorded incidence proportions increased significantly in Alberta (2001-2002: 4.5‰; 2017-2018: 5.0‰) and Nova Scotia (2001-2002: 3.3‰; 2017-2018: 3.8‰), but significantly decreased in Ontario (2001-2002: 6.2‰; 2017-2018: 4.7‰), Québec (2001-2002: 4.1‰; 2017-2018: 3.2‰) and Manitoba (2001-2002: 2.7‰; 2017-2018: 2.0‰). For almost all causes of death, a higher MRR was found among individuals with recorded SRD than in the general population. The causes of death in 2015-2016 with the highest MRR for SRD individuals were SRD, suicide, and non-suicide trauma in Alberta, Ontario, Manitoba, and Québec.
Linked AHD covering almost the entire population can be useful to monitor the medical service trends of SRD and, therefore, guide health services planning in Canadian provinces.
评估物质相关障碍(SRD)的记录诊断率、发病率比例和健康结果的时间变化,可以为减少与酒精和其他药物相关的危害提供公共卫生政策制定者信息。
报告加拿大各省按居住地报告的 SRD 的年度和累计记录诊断率和发病率比例,以及该人群的死亡率比(MRR)。
在加拿大五个省(艾伯塔省、马尼托巴省、安大略省、魁北克省和新斯科舍省)的链接行政健康数据库(AHD;医生索赔、住院和生命统计数据)上进行了分析。包括 12 岁及以上并注册了省级医疗保险的人群。使用国际疾病分类(ICD-9 或 ICD-10 代码)对 2001 年 4 月至 2018 年 3 月的 SRD 进行病例识别。
在研究期间,艾伯塔省(2001-2002 年:8.0‰;2017-2018 年:12.8‰)、安大略省(2001-2002 年:11.5‰;2017-2018 年:14.4‰)和新斯科舍省(2001-2002 年:6.4‰;2017-2018 年:12.7‰)的年度记录 SRD 诊断率增加,但马尼托巴省(2001-2002 年:5.5‰;2017-2018 年:5.4‰)和魁北克省(2001-2002 年和 2017-2018 年:7.5‰)保持稳定。所有省份的累计记录 SRD 诊断率稳步上升。记录的发病率比例在艾伯塔省(2001-2002 年:4.5‰;2017-2018 年:5.0‰)和新斯科舍省(2001-2002 年:3.3‰;2017-2018 年:3.8‰)显著增加,但在安大略省(2001-2002 年:6.2‰;2017-2018 年:4.7‰)、魁北克省(2001-2002 年:4.1‰;2017-2018 年:3.2‰)和马尼托巴省(2001-2002 年:2.7‰;2017-2018 年:2.0‰)显著下降。对于几乎所有的死亡原因,记录的 SRD 患者的死亡率比(MRR)都高于普通人群。2015-2016 年艾伯塔省、安大略省、马尼托巴省和魁北克省记录的 SRD 患者死亡率最高的原因是 SRD、自杀和非自杀性创伤。
涵盖几乎整个人群的链接 AHD 可用于监测 SRD 的医疗服务趋势,从而为加拿大各省的卫生服务规划提供指导。